Literature DB >> 4162486

Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.

K F Austen, E L Becker.   

Abstract

There is an absolute requirement for C'1, C'2, C'4, C'3, and C'5 in releasing histamine from rat peritoneal mast cells sensitized with rabbit anti-rat gamma globulin. This conclusion is based upon the restoration of histamine-releasing capacity by adding highly purified complement components to sera deficient in one or more of these components. Of special advantage was the availability of sera from humans with inborn or acquired deficiencies in a single component. The p-nitrophenyl ethyl phosphonates block this reaction by inhibiting an antigen-antibody-activated esterase which exists in a phosphonate resistant precursor state until activated by the interaction of the sensitized mast cell and serum complement. There is almost complete disparity between the ability of the phosphonates to inhibit complement-dependent histamine release by rabbit anti-RGG and to inactivate C'1a. Even though C'1a is required for complement-dependent histamine release by rabbit anti-RGG, this is not the esterase being blocked by the phosphonates under the experimental conditions used. The pattern of inhibition by the phosphonates of the antigen-antibody-activated esterase required for complement-dependent, noncytotoxic histamine release is remarkably similar to that of the esterase required for homocytotropic antibody-mediated histamine release. One possible implication is that these two quite different modes of carrying out antigen-antibody-induced histamine release from rat peritoneal mast cells lead to activation of the same esterase and share a common pathway.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4162486      PMCID: PMC2138227          DOI: 10.1084/jem.124.3.397

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  ENZYME INHIBITORY ACTIVITY OF CERTAIN PHOSPHONATE ESTERS AGAINST CHYMOTRYPSIN, TRYPSIN AND ACETYLCHOLINESTERASE.

Authors:  B J BOONE; E L BECKER; D H CANHAM
Journal:  Biochim Biophys Acta       Date:  1964-06-01

2.  ANAPHYLAXIS IN ISOLATED RAT MAST CELLS. III. LOCALISATION OF THE CHYMOTRYPSIN-TYPE PROESTERASE IN HEAT-LABILE SERUM COMPONENTS.

Authors:  R KELLER
Journal:  Int Arch Allergy Appl Immunol       Date:  1964

3.  THE MEASUREMENT OF SECOND COMPONENT OF HUMAN COMPLEMENT (C'2HU) BY ITS INTERACTION WITH EAC'1AGP,4GP CELLS.

Authors:  K F AUSTEN; F BEER
Journal:  J Immunol       Date:  1964-06       Impact factor: 5.422

4.  Concerning the mechanism of complement action. IV. The properties of activated first component of guinea pig complement.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1959-01       Impact factor: 5.422

5.  Further evidence of the existence of differences in the mechanism of immune cellular injury of sheep erythrocytes and rat mast cells.

Authors:  R Keller
Journal:  Experientia       Date:  1965-05-15

6.  Anaphylatoxin formation by purified human C'1 esterase.

Authors:  W Dias da Silva; I H Lepow
Journal:  J Immunol       Date:  1965-12       Impact factor: 5.422

7.  Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.

Authors:  E L Becker; K F Austen
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

8.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

9.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  11 in total

1.  Inhibitory effect of anti-allergic agent NCO-650 on histamine release induced by various secretagogues.

Authors:  M Takei; T Matumoto; K Endo; M Muramatu
Journal:  Agents Actions       Date:  1988-08

Review 2.  Human reagins: appraisal of the properties of the antibody of immediate-type hypersensitivity.

Authors:  J A Flick
Journal:  Bacteriol Rev       Date:  1972-09

3.  The role of the complement system in the pathogenesis of acute pulmonary oedema produced by nephrotoxic serum in rats.

Authors:  W D da Silva; M N Vieira; C R Diniz
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

4.  Comparative effects of drugs on four paw oedema models in the rat.

Authors:  D K Gemmell; J Cottney; A J Lewis
Journal:  Agents Actions       Date:  1979-04

5.  Histamine-releasing factor generated by the interaction of endotoxin with hamster serum.

Authors:  W A Hook; R Snyderman; S E Mergenhagen
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

6.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

7.  Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.

Authors:  E L Becker; K F Austen
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

8.  Mechanisms of the inhibition of chemotaxis by phosphonate esters.

Authors:  P A Ward; E L Becker
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

9.  Esterases of the polymorphonuclear leukocyte capable of hydrolyzing acetyl DL-phenyl-alanine beta-naphthyl ester. Relationship to the activatable esterase of chemotaxis.

Authors:  E L Becker; P A Ward
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

10.  Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat.

Authors:  D J Stechschulte; K F Austen; K J Bloch
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.